Clinical trial
A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
NCT00095823 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00095823 |
|---|---|
| Title | A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Aripiprazole as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder. |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Collaborators | Otsuka America Pharmaceutical Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | Antidepressant + Placebo, Antidepressant + Aripiprazole |
| Enrollment | 1,200 |
| Start date | Jun 1, 2004 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Nov 9, 2004 |
| Last update posted | Nov 25, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: